CTI BioPharma Corp. (DE) (CTIC): Share Price, Stock Analysis, Annual Report | Value Research Get CTI BioPharma Corp. (DE) (CTIC)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

CTI BioPharma Corp. (DE) (CTIC)

NASDAQ: CTIC

  • Market Capitalisation info

    $662 Mln


  • 12 Month Earnings info

    $-121 Mln

  • Price to Earnings info

    --

$5.79

As on 12-Aug-2022 16:00 EDT

up-down-arrow $0.081.40%

  • Prev Close info

    $5.71

  • Day's Openinfo

    $5.73

  • Today's Highinfo

    $5.92

  • Today's Lowinfo

    $5.63

  • Today's Volumeinfo

    4,075,201

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CTI BioPharma Corp. (DE) (CTIC)
133.47 -12.01 63.10 112.09 108.37 11.50 -12.09
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Small-Cap 600
-8.13 14.13 12.23 -5.78 11.43 9.16 11.05
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
CTI BioPharma Corp. (DE) (CTIC)
-22.98 103.80 115.38 -72.43 -34.25 -66.86 -47.88
S&P Small-Cap 600
25.27 9.57 20.86 -9.70 11.73 24.74 -3.36
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Pres, CEO, Interim Chief Medical Officer & Director

        Dr. Adam R. Craig M.B.A., M.D., Ph.D.

        Exec. VP, CFO & Sec.

        Mr. David H. Kirske

        Headquarters

        Seattle, WA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $662.29 Mln

        • Revenue (TTM) info

          $14.62 Mln

        • Earnings (TTM) info

          $-120.80 Mln

        • Cash info

          $95.87 Mln

        • Total Debt info

          $47.66 Mln

        • Insider's Holding

          0.20%

        • Liquidity info

          Low

        • 52 Week range info

          $1.43 - 7.80

        • Shares outstanding info

          114,385,000

        • 10 Years Aggregate:

          CFO: $-544.08 Mln

          EBITDA: $-635.83 Mln

          Net Profit: $-669.28 Mln

        About The Company

        • Business

          CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States.

        • IPO Date

          21-Mar-1997

        • Pres, CEO, Interim Chief Medical Officer & Director

          Dr. Adam R. Craig M.B.A., M.D., Ph.D.

        • Exec. VP, CFO & Sec.

          Mr. David H. Kirske

        • Listing info

          NASDAQ: CTIC

        • Country

          United States

        • Headquarters info

          Seattle, WA

        • Website info

          https://www.ctibiopharma.com